F Jablawi1,2, G A Schubert3, M Dafotakis4, J Pons-Kühnemann5, F-J Hans6, M Mull7. 1. From the Departments of Diagnostic and Interventional Neuroradiology (F.J., M.M.). 2. Department of Neurosurgery (F.J.). 3. Neurosurgery (G.A.S.). 4. Neurology (M.D.), RWTH Aachen University Hospital, Aachen, Germany. 5. Medical Statistics, Institute for Medical Informatics (J.P.-K.), Justus-Liebig-University, Giessen, Germany. 6. Department of Neurosurgery (F.-J.H.), Paracelsus Kliniken, Osnabrück, Germany. 7. From the Departments of Diagnostic and Interventional Neuroradiology (F.J., M.M.) mmull@ukaachen.de.
Abstract
BACKGROUND AND PURPOSE: The impact of various radiologic and clinical features on the long-term outcome in spinal dural arteriovenous fistulas is still unclear; thus, they are the purpose of this study. MATERIALS AND METHODS: We retrospectively analyzed our medical data base for all patients treated for spinal dural arteriovenous fistula in our institution between 2006 and 2016. Patient age, neurologic status at the time of diagnosis, the duration of symptoms from onset to diagnosis, and follow-up information were evaluated. The extent of medullary T2WI hyperintensity, intramedullary contrast enhancement, and elongation of perimedullary veins on MR imaging at the time of diagnosis were additionally analyzed. RESULTS: Data for long-term outcome analysis were available in 40 patients with a mean follow-up of 52 months (median, 50.5 months; range, 3-159 months). The mean age at the time of diagnosis was 69.27 ± 9 years (median, 71 years; range, 53-84 years) with a male predominance (n = 32; 80%). The mean duration of symptoms was 20.2 months (median, 10 months; range, 1-120 months). Shorter duration of symptoms at the time of diagnosis was significantly correlated with better outcome of symptoms (P < .05). CONCLUSIONS: Spinal dural arteriovenous fistulas are characterized by interindividually variable clinical presentations, which make a determination of specific predictors for long-term outcome more difficult. Fast and sufficient diagnosis might result in a better outcome after treatment. The diagnosis of spinal dural arteriovenous fistula remains markedly delayed, reflecting an ongoing lack of knowledge and awareness among treating physicians of this rare-but-serious disease.
BACKGROUND AND PURPOSE: The impact of various radiologic and clinical features on the long-term outcome in spinal dural arteriovenous fistulas is still unclear; thus, they are the purpose of this study. MATERIALS AND METHODS: We retrospectively analyzed our medical data base for all patients treated for spinal dural arteriovenous fistula in our institution between 2006 and 2016. Patient age, neurologic status at the time of diagnosis, the duration of symptoms from onset to diagnosis, and follow-up information were evaluated. The extent of medullary T2WI hyperintensity, intramedullary contrast enhancement, and elongation of perimedullary veins on MR imaging at the time of diagnosis were additionally analyzed. RESULTS: Data for long-term outcome analysis were available in 40 patients with a mean follow-up of 52 months (median, 50.5 months; range, 3-159 months). The mean age at the time of diagnosis was 69.27 ± 9 years (median, 71 years; range, 53-84 years) with a male predominance (n = 32; 80%). The mean duration of symptoms was 20.2 months (median, 10 months; range, 1-120 months). Shorter duration of symptoms at the time of diagnosis was significantly correlated with better outcome of symptoms (P < .05). CONCLUSIONS:Spinal dural arteriovenous fistulas are characterized by interindividually variable clinical presentations, which make a determination of specific predictors for long-term outcome more difficult. Fast and sufficient diagnosis might result in a better outcome after treatment. The diagnosis of spinal dural arteriovenous fistula remains markedly delayed, reflecting an ongoing lack of knowledge and awareness among treating physicians of this rare-but-serious disease.
Authors: Andrea Saladino; John L D Atkinson; Alejandro A Rabinstein; David G Piepgras; W Richard Marsh; William E Krauss; Timothy J Kaufmann; Giuseppe Lanzino Journal: Neurosurgery Date: 2010-11 Impact factor: 4.654
Authors: Steven W Hetts; Parham Moftakhar; Joey D English; Christopher F Dowd; Randall T Higashida; Michael T Lawton; Vanja C Douglas; Van V Halbach Journal: J Neurosurg Spine Date: 2012-02-10
Authors: Camillo Sherif; Andreas Gruber; Gerhard Bavinzski; Harald Standhardt; Georg Widhalm; Daniel Gibson; Bernd Richling; Engelbert Knosp Journal: Neuroradiology Date: 2007-11-20 Impact factor: 2.804